Pancreatic Cancer Research

ResearcherUniversity of California, San FranciscoNo recent work listed

Charles S. Craik

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7704-9185; OpenAlex author ID A5087001996; NIH RePORTER profile ID 1896956. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
1
Labs led
1
Collaborators
5
Papers, trials and grants by year

2016: 1 paper, 1 grant · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. Addressing the unmet clinical need for low-volume assays in early diagnosis of pancreatic cancer. Co-author DOI 10.3389/fgstr.2023.1258998↗
  2. Procathepsin E is highly abundant but minimally active in pancreatic ductal adenocarcinoma tumors. Last author DOI 10.1515/hsz-2016-0138↗

Grants 1

  1. Non-invasive Differentiation of Benign Lesions from Aggressive Pancreatic Cancer R21CA185689↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kimberly Saunders Kirkwood · 1 shared paper, 1 shared grant, 2016–2023 · strength 0.43
  2. Daniel A. Sheik · 1 shared paper, 2023 · strength 0.18
  3. Vincent Jo Davisson · 1 shared paper, 2023 · strength 0.18
  4. Anthony John O’Donoghue · 1 shared paper, 2016 · strength 0.07
  5. Douglas Hanahan · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.